Related Experiment Video
Updated: May 6, 2026

Assessment of Cardiac Morphological and Functional Changes in Mouse Model of Transverse Aortic Constriction by Echocardiographic Imaging
Published on: June 21, 2016
Morphological anomalies in obstructive hypertrophic cardiomyopathy: Insights from four-dimensional computed
Yuki Izumi1, Shuichiro Takanashi2, Mitsunobu Kitamura1
1Hypertrophic Cardiomyopathy Center, Sakakibara Heart Institute, Tokyo, Japan; Department of Cardiology, Sakakibara Heart Institute, Tokyo, Japan.
Insights
Hypertrophic cardiomyopathy (HCM) involves complex anatomy beyond septal hypertrophy. Four-dimensional computed tomography (4D-CT) provides detailed morphological assessment for improved surgical planning in obstructive HCM.
Area of Science:
- Cardiology
- Medical Imaging
- Genetics
Background:
- Hypertrophic cardiomyopathy (HCM) is a genetic heart disease.
- Left ventricular outflow tract (LVOT) obstruction significantly impacts HCM symptoms and prognosis.
- Traditional understanding focused on septal hypertrophy, but other anomalies are now recognized.
Purpose of the Study:
- To highlight the importance of comprehensive morphological assessment in obstructive HCM.
- To evaluate the role of four-dimensional computed tomography (4D-CT) in characterizing complex HCM anatomy.
- To demonstrate how detailed 4D-CT findings can guide septal reduction therapy.
Main Methods:
- Review of recent evidence on HCM morphology.
- Comparison of imaging modalities for assessing anomalous structures in HCM.
- Application of 4D-CT for detailed evaluation of mitral valve, papillary muscles, and muscle bundles.
- Utilizing 4D-CT for surgical planning in a specialized HCM center.
Main Results:
- HCM involves complex anatomical variations including mitral valve and papillary muscle anomalies, and apical-basal muscle bundles.
- Four-dimensional computed tomography offers superior spatial resolution and multiplanar capabilities for detailed morphological assessment.
- 4D-CT enables precise evaluation of subaortic stenosis and right ventricular outflow tract obstruction.
- Detailed 4D-CT assessment aids in planning surgical correction for obstructive HCM.
Conclusions:
- Accurate morphological assessment is crucial for effective septal reduction therapy in obstructive HCM.
- Four-dimensional computed tomography is a valuable tool for detailed anatomical evaluation in HCM.
- Comprehensive 4D-CT-guided surgical planning may improve outcomes for patients with obstructive HCM.
Abstract:
Hypertrophic cardiomyopathy (HCM) is a genetic disorder in which left ventricular outflow tract obstruction critically affects symptoms and prognosis. Traditionally, left ventricular outflow tract obstruction was primarily attributed to septal hypertrophy with systolic anterior motion of the mitral valve. However, recent evidence highlights significant contributions from the mitral valve and papillary muscle anomalies, as well as an apical-basal muscle bundle observed in HCM patients. Accurate morphological assessment is essential when considering septal reduction therapy. While transesophageal echocardiography and cardiac magnetic resonance are recommended for assessing the anomalous structures, four-dimensional computed tomography offers superior spatial resolution and multiplanar reconstruction capabilities. These features enable the evaluation of details of the morphological anomalies, such as the apical-basal muscle band, papillary muscle anomalies, subaortic stenosis, and right ventricular outflow tract obstruction. Based on the detailed assessment of these morphological features, four-dimensional computed tomography has been utilized for planning of surgical correction in a comprehensive HCM center. This approach facilitates the intervention strategies and may improve outcomes in septal reduction therapy for obstructive HCM.
Related Concept Videos
Mitral Stenosis II: Clinical features and Diagnostic Tests
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy V: Interprofessional Care

